Geographically, China dominated BRIC IVD Market & emerging countries in 2016. Large share of this country can be attributed to rising healthcare expenditure, increasing acceptance of personalized medicine, & increasing awareness towards technologically advanced products in this country. China also expected to register highest CAGR, due to growth in research activities & increasing investments by leading players & government agencies in country.
In BRIC In Vitro Diagnostics Market report segmented by product & service, technology, application, end user, & country. Based on application, market segmented into diabetes, infectious diseases, oncology/cancer, cardiology, HIV/AIDS, autoimmune diseases, nephrology, drug testing/pharmacogenomics. Infectious diseases segment accounted for largest share of market in 2016, owing to rising incidence of tuberculosis (TB), hepatitis, & hospital-acquired infections.
Complete report on IVD Market spread across 278 Pages, Profiling 13 Companies and Supported with 138 Tables and 69 Figures is now available at http://www.reportsnreports.com/reports/992559-ivd-market-in-bric-by-product-service-instruments-reagents-software-technology-immunoassay-hematology-microbiology-application-diabetes-cardiology-infectious-diseases-country-brazil-russia-india-st-to-2022.html .
In IVD market report, it segmented by product & service, technology, application, end user, and country. Based on technology, the market is broadly segmented into immunoassays/immunochemistry, clinical chemistry, molecular diagnostics, hematology, clinical microbiology, coagulation & hemostasis, and other technologies. The molecular diagnostics segment is estimated to register the highest CAGR during the forecast period of 2017 to 2022.
Target Audience of IVD Market is as Follows,
- IVD product manufacturers
- Group purchase organizations (GPOs)
- Original equipment manufacturers (OEM)
- Pathologists and pathology laboratories
- Distributors of IVD products
- Hospitals and clinics
- Healthcare institutions
- Research institutes
- Market research and consulting Firms
IVD Market broadly segmented into immunoassays/immunochemistry, clinical chemistry, molecular diagnostics, hematology, clinical microbiology, coagulation & hemostasis technologies. Molecular diagnostics segment estimated to register highest CAGR during forecast period of 2017 to 2022. Rising prevalence of infectious diseases, cancer, & various genetic disorders. Growing demand for blood screening & increasing application of molecular diagnostic technologies in pharmacogenetics and point-of-care testing expected to drive growth of market during.
Interested in this report, Get sample copy of this research now
IVD Market & emerging countries expected to reach USD 15.71 Billion by 2022 from USD 10.60 Billion in 2017, at a CAGR of 8.2%. Key factors driving growth of market are growing patient awareness of personalized medicine, increasing prevalence of lifestyle & chronic diseases, growth in number of private diagnostic centers, & improving healthcare system in emerging countries.
BRIC IVD Market Competitive Landscape
6 Competitive Benchmarking
Key players BRIC IVD Market are Roche Diagnostics (Switzerland), Abbott Laboratories Inc. (U.S.), Siemens Healthineers (Germany), Danaher Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), Sysmex Corporation (Japan), Bio-Rad Laboratories, Inc. (U.S.), bioMérieux (France), and Becton, Dickinson and Company (U.S.), Johnson & Johnson (U.S.), QIAGEN N.V. (Germany), Ortho-Clinical Diagnostics, Inc. (U.S.), and Diasorin S.P.A. (Italy).
Click now for more Details, Queries, Other Information and Discount on this study “IVD Market in BRIC by Product & Service (Instruments, Reagents, Software), Technology (Immunoassay, Hematology, Microbiology), Application (Diabetes, Cardiology, Infectious Diseases), Country (Brazil, Russia, India, China) – Forecast to 2022” report @ http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=992559 .
In this report, the BRIC IVD Market countries has been studied at the country level. In 2016, China represented the largest BRIC IVD Market countries, followed by Brazil. It is also expected to register the highest growth during the forecast period.
The growth of this geographic segment is driven by improving healthcare infrastructure, significant economic development in China, and rising focus of key market players in this emerging country.